Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA Hepatitis Update - Pegasys and Copegus

On August 22, 2011, the FDA approved the combination of Pegasys and Copegus for the treatment of chronic hepatitis C virus ( HCV ) infection in pediatric patients 5 through 17 years of age.

REFINE

medications
- - Remove Pegasys filter (-) Remove Pegasys filter Pegasys
conditions
- - Apply Infectious Disease filter Infectious Disease (1) Apply Infectious Disease filter
    Apply Sexually Transmitted Disease filter Sexually Transmitted Disease (1) Apply Sexually Transmitted Disease filter
    Apply Hepatitis filter Hepatitis (1) Apply Hepatitis filter